Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation vs. no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Publication date: Available online 20 June 2020Source: American Heart JournalAuthor(s): Yan Yan, Xiao Wang, Jincheng Guo, Yongjun Li, Hui Ai, Wei Gong, Bin Que, Lei Zhen, Jiapeng Lu, Changsheng Ma, Gilles Montalescot, Shaoping Nie
Source: American Heart Journal - Category: Cardiology Source Type: research